Corcept Therapeutics Aktie
WKN: 529882 / ISIN: US2183521028
|
04.11.2025 23:08:16
|
Corcept Therapeutics Inc Q3 Profit Drops, But Beats Estimates
(RTTNews) - Corcept Therapeutics Inc (CORT) released earnings for third quarter that Dropped, from the same period last year but beat the Street estimates.
The company's bottom line totaled $19.35 million, or $0.16 per share. This compares with $46.69 million, or $0.41 per share, last year.
Analysts on average had expected the company to earn $0.14 per share. Analysts' estimates typically exclude special items.
The company's revenue for the period rose 13.7% to $207.63 million from $182.54 million last year.
Corcept Therapeutics Inc earnings at a glance (GAAP) :
-Earnings: $19.35 Mln. vs. $46.69 Mln. last year. -EPS: $0.16 vs. $0.41 last year. -Revenue: $207.63 Mln vs. $182.54 Mln last year.
-Guidance: Full year revenue guidance: $800 – $850 Mln
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Corcept Therapeutics Inc.mehr Nachrichten
Analysen zu Corcept Therapeutics Inc.mehr Analysen
Aktien in diesem Artikel
| Corcept Therapeutics Inc. | 63,78 | 8,69% |
|